HSBC Holdings’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $414M | Sell |
14,769,053
-1,165,180
| -7% | -$31M | 0.22% | 85 |
|
|
2025
Q4 | $397M | Sell |
15,934,233
-1,305,750
| -8% | -$32.9M | 0.2% | 89 |
|
|
2025
Q3 | $436M | Buy |
17,239,983
+1,244,523
| +8% | +$30.7M | 0.24% | 68 |
|
|
2025
Q2 | $388M | Buy |
15,995,460
+816,127
| +5% | +$19M | 0.23% | 68 |
|
|
2025
Q1 | $382M | Sell |
15,179,333
-1,458,403
| -9% | -$38.2M | 0.24% | 73 |
|
|
2024
Q4 | $441M | Sell |
16,637,736
-1,347,656
| -7% | -$36.6M | 0.26% | 62 |
|
|
2024
Q3 | $520M | Sell |
17,985,392
-365,553
| -2% | -$10.7M | 0.3% | 52 |
|
|
2024
Q2 | $513M | Buy |
18,350,945
+891,672
| +5% | +$24.5M | 0.31% | 52 |
|
|
2024
Q1 | $484M | Buy |
17,459,273
+2,764,338
| +19% | +$76.7M | 0.33% | 47 |
|
|
2023
Q4 | $422M | Buy |
14,694,935
+2,196,700
| +18% | +$66.4M | 0.37% | 42 |
|
|
2023
Q3 | $414M | Buy |
12,498,235
+63,694
| +0.5% | +$2.25M | 0.43% | 35 |
|
|
2023
Q2 | $456M | Buy |
12,434,541
+1,808,554
| +17% | +$70.4M | 0.46% | 32 |
|
|
2023
Q1 | $433M | Sell |
10,625,987
-609,614
| -5% | -$26.3M | 0.52% | 29 |
|
|
2022
Q4 | $575M | Buy |
11,235,601
+2,470,744
| +28% | +$118M | 0.66% | 22 |
|
|
2022
Q3 | $387M | Buy |
8,764,857
+261,708
| +3% | +$12.7M | 0.63% | 22 |
|
|
2022
Q2 | $444M | Buy |
8,503,149
+182,680
| +2% | +$9.31M | 0.62% | 22 |
|
|
2022
Q1 | $434M | Buy |
8,320,469
+93,381
| +1% | +$4.85M | 0.53% | 24 |
|
|
2021
Q4 | $485M | Sell |
8,227,088
-990,612
| -11% | -$49.1M | 0.45% | 26 |
|
|
2021
Q3 | $399M | Sell |
9,217,700
-683,250
| -7% | -$30.3M | 0.4% | 34 |
|
|
2021
Q2 | $388M | Sell |
9,900,950
-901,066
| -8% | -$35M | 0.41% | 36 |
|
|
2021
Q1 | $392M | Sell |
10,802,016
-189,999
| -2% | -$6.75M | 0.46% | 32 |
|
|
2020
Q4 | $402M | Buy |
10,992,015
+2,458,567
| +29% | +$90.2M | 0.54% | 27 |
|
|
2020
Q3 | $297M | Buy |
8,533,448
+602,004
| +8% | +$21.1M | 0.47% | 33 |
|
|
2020
Q2 | $246M | Sell |
7,931,444
-449,082
| -5% | -$15.3M | 0.47% | 35 |
|
|
2020
Q1 | $260M | Sell |
8,380,526
-339,370
| -4% | -$11.6M | 0.6% | 23 |
|
|
2019
Q4 | $323M | Buy |
8,719,896
+1,029,709
| +13% | +$36.7M | 0.56% | 20 |
|
|
2019
Q3 | $262M | Buy |
7,690,187
+378,142
| +5% | +$13.8M | 0.49% | 23 |
|
|
2019
Q2 | $301M | Buy |
7,312,045
+774,702
| +12% | +$30.8M | 0.57% | 18 |
|
|
2019
Q1 | $263M | Sell |
6,537,343
-2,352,072
| -26% | -$94.2M | 0.48% | 27 |
|
|
2018
Q4 | $368M | Sell |
8,889,415
-2,006,846
| -18% | -$83.3M | 0.68% | 17 |
|
|
2018
Q3 | $456M | Buy |
10,896,261
+2,224,953
| +26% | +$85.7M | 0.73% | 15 |
|
|
2018
Q2 | $298M | Sell |
8,671,308
-3,200,221
| -27% | -$109M | 0.53% | 22 |
|
|
2018
Q1 | $400M | Sell |
11,871,529
-1,405,243
| -11% | -$48.3M | 0.6% | 19 |
|
|
2017
Q4 | $456M | Buy |
13,276,772
+224,634
| +2% | +$7.66M | 0.66% | 28 |
|
|
2017
Q3 | $442M | Buy |
13,052,138
+3,277,775
| +34% | +$105M | 0.71% | 16 |
|
|
2017
Q2 | $312M | Buy |
9,774,363
+1,252,364
| +15% | +$39.5M | 0.57% | 24 |
|
|
2017
Q1 | $277M | Sell |
8,521,999
-261,271
| -3% | -$8.24M | 0.58% | 24 |
|
|
2016
Q4 | $271M | Buy |
8,783,270
+508,686
| +6% | +$15.5M | 0.63% | 17 |
|
|
2016
Q3 | $265M | Buy |
8,274,584
+1,145,229
| +16% | +$38.3M | 0.66% | 19 |
|
|
2016
Q2 | $238M | Sell |
7,129,355
-263,603
| -4% | -$8.41M | 0.65% | 15 |
|
|
2016
Q1 | $208M | Sell |
7,392,958
-6,446,862
| -47% | -$184M | 0.59% | 27 |
|
|
2015
Q4 | $424M | Sell |
13,839,820
-854,271
| -6% | -$26.9M | 1.02% | 7 |
|
|
2015
Q3 | $438M | Buy |
14,694,091
+4,680,472
| +47% | +$150M | 1.1% | 9 |
|
|
2015
Q2 | $319M | Sell |
10,013,619
-571,180
| -5% | -$18.6M | 0.65% | 26 |
|
|
2015
Q1 | $350M | Sell |
10,584,799
-3,354,320
| -24% | -$107M | 0.67% | 26 |
|
|
2014
Q4 | $412M | Sell |
13,939,119
-2,906,828
| -17% | -$83.3M | 0.86% | 16 |
|
|
2014
Q3 | $474M | Buy |
16,845,947
+3,194,059
| +23% | +$89.6M | 0.99% | 14 |
|
|
2014
Q2 | $384M | Sell |
13,651,888
-1,654,945
| -11% | -$47.2M | 0.83% | 18 |
|
|
2014
Q1 | $466M | Buy |
15,306,833
+3,596,868
| +31% | +$107M | 1.11% | 12 |
|
|
2013
Q4 | $340M | Sell |
11,709,965
-777,457
| -6% | -$22.6M | 0.89% | 15 |
|
|
2013
Q3 | $340M | Buy |
12,487,422
+1,066,052
| +9% | +$29M | 0.93% | 11 |
|
|
2013
Q2 | $304M | Buy |
+11,421,370
| New | +$316M | 0.91% | 17 |
|
Other funds holding PFE
VCM
VPM
HSBC Holdings's PFE Position: Q1 2026 in Review
HSBC Holdings reduced its Pfizer (PFE) stake by 7.3% in Q1 2026, selling an estimated $31M and leaving 14,769,053 shares worth $414M. The position accounts for 0.22% of the portfolio, ranked #85.
HSBC Holdings first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $575M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- HSBC Holdings held 14,769,053 shares of Pfizer worth $414M as of Q1 2026.
- HSBC Holdings sold 1,165,180 Pfizer shares in Q1 2026, an estimated $31M.
- Pfizer made up 0.22% of HSBC Holdings's portfolio in Q1 2026, its #85 holding.
- HSBC Holdings first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- HSBC Holdings's Pfizer position peaked at $575M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.